 Denis Bensard
Concepts (555)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 35 | 2022 | 321 | 7.030 |
Why?
| | Wounds and Injuries | 23 | 2025 | 962 | 4.210 |
Why?
| | Trauma Centers | 40 | 2023 | 466 | 4.070 |
Why?
| | Shock | 9 | 2025 | 110 | 3.620 |
Why?
| | Injury Severity Score | 45 | 2023 | 599 | 3.420 |
Why?
| | Abdominal Injuries | 13 | 2022 | 130 | 2.820 |
Why?
| | Blood Transfusion | 17 | 2022 | 409 | 2.580 |
Why?
| | Shock, Hemorrhagic | 6 | 2021 | 199 | 2.130 |
Why?
| | Glasgow Coma Scale | 8 | 2023 | 218 | 1.990 |
Why?
| | Wounds, Penetrating | 5 | 2023 | 72 | 1.790 |
Why?
| | Triage | 9 | 2025 | 250 | 1.640 |
Why?
| | Spleen | 7 | 2021 | 508 | 1.540 |
Why?
| | Craniocerebral Trauma | 6 | 2022 | 179 | 1.490 |
Why?
| | Child | 101 | 2025 | 22740 | 1.470 |
Why?
| | Brain Injuries | 9 | 2015 | 507 | 1.440 |
Why?
| | Blood Coagulation Disorders | 5 | 2022 | 198 | 1.370 |
Why?
| | Retrospective Studies | 73 | 2025 | 17330 | 1.360 |
Why?
| | Thoracic Injuries | 4 | 2018 | 71 | 1.330 |
Why?
| | Thoracotomy | 8 | 2020 | 88 | 1.310 |
Why?
| | Blood Component Transfusion | 3 | 2022 | 102 | 1.210 |
Why?
| | Child, Preschool | 62 | 2025 | 11868 | 1.120 |
Why?
| | Thrombelastography | 5 | 2022 | 192 | 1.070 |
Why?
| | Liver | 9 | 2021 | 1899 | 1.060 |
Why?
| | Tomography, X-Ray Computed | 15 | 2022 | 2770 | 1.040 |
Why?
| | Laparoscopy | 11 | 2015 | 481 | 1.020 |
Why?
| | Adolescent | 66 | 2025 | 22577 | 0.940 |
Why?
| | Appendicitis | 7 | 2021 | 150 | 0.930 |
Why?
| | Appendectomy | 6 | 2021 | 90 | 0.890 |
Why?
| | Resuscitation | 5 | 2022 | 312 | 0.890 |
Why?
| | Emergency Service, Hospital | 8 | 2023 | 2383 | 0.850 |
Why?
| | Hematocrit | 2 | 2015 | 108 | 0.850 |
Why?
| | Infant | 48 | 2025 | 10091 | 0.830 |
Why?
| | Erythrocyte Transfusion | 3 | 2022 | 225 | 0.760 |
Why?
| | Emergency Medical Services | 3 | 2023 | 684 | 0.740 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2933 | 0.730 |
Why?
| | Decision Support Techniques | 4 | 2022 | 480 | 0.730 |
Why?
| | Child Abuse | 6 | 2014 | 553 | 0.730 |
Why?
| | Humans | 137 | 2025 | 145783 | 0.730 |
Why?
| | Heart Rate | 6 | 2023 | 856 | 0.730 |
Why?
| | Length of Stay | 13 | 2022 | 1350 | 0.700 |
Why?
| | Risk Adjustment | 1 | 2022 | 85 | 0.680 |
Why?
| | Early Medical Intervention | 1 | 2022 | 63 | 0.670 |
Why?
| | Blood Pressure | 7 | 2023 | 1782 | 0.660 |
Why?
| | Male | 100 | 2025 | 73011 | 0.650 |
Why?
| | Radiation Exposure | 1 | 2020 | 63 | 0.610 |
Why?
| | Intubation, Gastrointestinal | 3 | 2020 | 81 | 0.590 |
Why?
| | Hypotension | 3 | 2016 | 127 | 0.580 |
Why?
| | Patient Selection | 2 | 2022 | 739 | 0.560 |
Why?
| | Female | 78 | 2025 | 79045 | 0.560 |
Why?
| | Pylorus | 2 | 2010 | 17 | 0.550 |
Why?
| | Enteral Nutrition | 2 | 2020 | 217 | 0.550 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2010 | 10 | 0.550 |
Why?
| | Catheterization, Central Venous | 2 | 2018 | 123 | 0.540 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 558 | 0.530 |
Why?
| | Lung Diseases | 7 | 2022 | 782 | 0.530 |
Why?
| | Colorado | 26 | 2022 | 4556 | 0.530 |
Why?
| | Head Injuries, Closed | 3 | 2012 | 49 | 0.480 |
Why?
| | Bacteremia | 1 | 2018 | 222 | 0.470 |
Why?
| | Bicycling | 1 | 2017 | 117 | 0.470 |
Why?
| | Hemoglobins | 3 | 2022 | 386 | 0.460 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 12 | 0.460 |
Why?
| | Gastrostomy | 2 | 2015 | 130 | 0.450 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 453 | 0.450 |
Why?
| | Intestinal Volvulus | 1 | 2015 | 23 | 0.440 |
Why?
| | Rehydration Solutions | 1 | 2014 | 9 | 0.430 |
Why?
| | Isotonic Solutions | 1 | 2014 | 42 | 0.430 |
Why?
| | Thrombosis | 1 | 2018 | 400 | 0.430 |
Why?
| | Shock, Traumatic | 1 | 2014 | 14 | 0.420 |
Why?
| | Lung | 14 | 2022 | 4116 | 0.420 |
Why?
| | Age Factors | 10 | 2025 | 3346 | 0.420 |
Why?
| | Infant, Newborn | 17 | 2020 | 6465 | 0.400 |
Why?
| | Preoperative Care | 2 | 2015 | 380 | 0.400 |
Why?
| | Multiple Trauma | 7 | 2014 | 121 | 0.390 |
Why?
| | Vascular System Injuries | 3 | 2021 | 81 | 0.390 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 237 | 0.380 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2013 | 100 | 0.370 |
Why?
| | Acidosis | 1 | 2013 | 105 | 0.370 |
Why?
| | Laparotomy | 7 | 2023 | 113 | 0.370 |
Why?
| | Critical Illness | 2 | 2018 | 900 | 0.360 |
Why?
| | Tracheostomy | 1 | 2014 | 142 | 0.360 |
Why?
| | Sensitivity and Specificity | 6 | 2022 | 2000 | 0.360 |
Why?
| | Risk Assessment | 4 | 2021 | 3752 | 0.350 |
Why?
| | Registries | 12 | 2025 | 2410 | 0.350 |
Why?
| | Risk Factors | 15 | 2022 | 10919 | 0.350 |
Why?
| | Referral and Consultation | 1 | 2018 | 869 | 0.340 |
Why?
| | Prognosis | 10 | 2023 | 4330 | 0.340 |
Why?
| | Spinal Cord Injuries | 2 | 2014 | 235 | 0.320 |
Why?
| | Treatment Outcome | 18 | 2020 | 11794 | 0.290 |
Why?
| | Mass Screening | 2 | 2019 | 1361 | 0.270 |
Why?
| | Viscera | 2 | 2005 | 17 | 0.270 |
Why?
| | Survival Rate | 9 | 2025 | 2094 | 0.260 |
Why?
| | Critical Pathways | 1 | 2009 | 111 | 0.260 |
Why?
| | Wounds, Gunshot | 2 | 2022 | 258 | 0.260 |
Why?
| | Lipopolysaccharides | 10 | 2004 | 858 | 0.260 |
Why?
| | Thoracoscopy | 4 | 2006 | 60 | 0.250 |
Why?
| | Accidents, Home | 2 | 2004 | 33 | 0.240 |
Why?
| | Adult | 31 | 2025 | 40881 | 0.240 |
Why?
| | Endotoxins | 7 | 1999 | 217 | 0.240 |
Why?
| | Pyelonephritis, Xanthogranulomatous | 1 | 2006 | 3 | 0.240 |
Why?
| | Radiation Dosage | 2 | 2020 | 193 | 0.230 |
Why?
| | Heart Arrest | 3 | 2018 | 411 | 0.220 |
Why?
| | Carcinoma, Papillary | 1 | 2025 | 82 | 0.220 |
Why?
| | Receptors, Adrenergic, beta | 3 | 1994 | 58 | 0.210 |
Why?
| | Digestive System Surgical Procedures | 1 | 2005 | 112 | 0.210 |
Why?
| | Follow-Up Studies | 9 | 2022 | 5428 | 0.210 |
Why?
| | Surgeons | 2 | 2021 | 340 | 0.210 |
Why?
| | Leg Injuries | 1 | 2004 | 25 | 0.210 |
Why?
| | Incidence | 12 | 2020 | 2934 | 0.200 |
Why?
| | Neutrophils | 13 | 2002 | 1127 | 0.200 |
Why?
| | Surgical Wound | 1 | 2023 | 27 | 0.190 |
Why?
| | Intestines | 2 | 2004 | 354 | 0.180 |
Why?
| | Precipitating Factors | 1 | 2022 | 6 | 0.180 |
Why?
| | Anticoagulants | 3 | 2019 | 748 | 0.180 |
Why?
| | Pediatric Emergency Medicine | 1 | 2022 | 24 | 0.170 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 5 | 0.170 |
Why?
| | False Positive Reactions | 1 | 2022 | 123 | 0.170 |
Why?
| | Fundoplication | 2 | 2015 | 52 | 0.170 |
Why?
| | Heart Injuries | 1 | 2021 | 42 | 0.170 |
Why?
| | Intracranial Pressure | 1 | 2022 | 65 | 0.170 |
Why?
| | Hypovolemia | 1 | 2021 | 12 | 0.170 |
Why?
| | Logistic Models | 3 | 2016 | 2139 | 0.160 |
Why?
| | Jejunostomy | 1 | 2020 | 14 | 0.160 |
Why?
| | Early Diagnosis | 1 | 2022 | 251 | 0.160 |
Why?
| | Intraoperative Complications | 1 | 2022 | 157 | 0.160 |
Why?
| | Time Factors | 10 | 2014 | 7134 | 0.160 |
Why?
| | Stomach | 1 | 2020 | 111 | 0.150 |
Why?
| | Plasma | 1 | 2022 | 223 | 0.150 |
Why?
| | Postoperative Care | 3 | 2019 | 286 | 0.150 |
Why?
| | Frailty | 1 | 2023 | 205 | 0.150 |
Why?
| | Prospective Studies | 7 | 2022 | 8078 | 0.150 |
Why?
| | Cerebrovascular Trauma | 1 | 2019 | 21 | 0.150 |
Why?
| | Hospital Mortality | 2 | 2014 | 1038 | 0.150 |
Why?
| | Salmonella typhimurium | 6 | 2002 | 188 | 0.150 |
Why?
| | Heart | 2 | 1994 | 626 | 0.150 |
Why?
| | Phlebotomy | 1 | 2019 | 22 | 0.150 |
Why?
| | Respiration, Artificial | 3 | 2014 | 714 | 0.140 |
Why?
| | Mortality | 1 | 2022 | 381 | 0.140 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 289 | 0.140 |
Why?
| | Diagnosis, Differential | 5 | 2014 | 1512 | 0.140 |
Why?
| | Isoproterenol | 4 | 1998 | 96 | 0.140 |
Why?
| | Central Venous Catheters | 1 | 2018 | 53 | 0.140 |
Why?
| | United States | 8 | 2025 | 16126 | 0.140 |
Why?
| | Platelet Activating Factor | 3 | 1992 | 45 | 0.130 |
Why?
| | Firearms | 2 | 2022 | 436 | 0.130 |
Why?
| | Cholestasis | 1 | 2000 | 214 | 0.130 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 115 | 0.130 |
Why?
| | Colforsin | 4 | 2001 | 47 | 0.130 |
Why?
| | Abdomen, Acute | 1 | 1997 | 21 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2022 | 1115 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2025 | 928 | 0.130 |
Why?
| | Stroke | 2 | 2019 | 1271 | 0.130 |
Why?
| | Patient Readmission | 2 | 2020 | 773 | 0.120 |
Why?
| | Immune System Diseases | 1 | 1997 | 37 | 0.120 |
Why?
| | Health Care Costs | 1 | 2020 | 425 | 0.120 |
Why?
| | Algorithms | 2 | 2021 | 1851 | 0.120 |
Why?
| | Hospital Charges | 1 | 2016 | 46 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1150 | 0.120 |
Why?
| | Surgery Department, Hospital | 1 | 2016 | 22 | 0.120 |
Why?
| | Hospitalization | 4 | 2016 | 2461 | 0.120 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2015 | 339 | 0.120 |
Why?
| | Hospital Rapid Response Team | 1 | 2016 | 20 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3418 | 0.120 |
Why?
| | Myocardial Reperfusion Injury | 4 | 1992 | 139 | 0.120 |
Why?
| | Chemokines | 3 | 2001 | 217 | 0.120 |
Why?
| | Cause of Death | 2 | 2014 | 472 | 0.120 |
Why?
| | Multiple Organ Failure | 4 | 2003 | 120 | 0.120 |
Why?
| | Hemostatic Techniques | 1 | 2016 | 52 | 0.110 |
Why?
| | Exsanguination | 2 | 2012 | 18 | 0.110 |
Why?
| | Splenectomy | 1 | 2015 | 61 | 0.110 |
Why?
| | Medical Futility | 1 | 2015 | 32 | 0.110 |
Why?
| | Funnel Chest | 2 | 2005 | 29 | 0.110 |
Why?
| | Research Design | 1 | 2022 | 1139 | 0.110 |
Why?
| | Intensive Care Units | 1 | 2022 | 924 | 0.110 |
Why?
| | Intestine, Small | 1 | 1996 | 167 | 0.110 |
Why?
| | Specialization | 1 | 2016 | 137 | 0.110 |
Why?
| | Arterial Occlusive Diseases | 1 | 1995 | 90 | 0.110 |
Why?
| | Benchmarking | 1 | 2016 | 191 | 0.110 |
Why?
| | Ultrasonography | 4 | 2010 | 788 | 0.110 |
Why?
| | Accidents | 1 | 2014 | 46 | 0.100 |
Why?
| | Child Advocacy | 1 | 2014 | 31 | 0.100 |
Why?
| | Rats | 19 | 2002 | 5585 | 0.100 |
Why?
| | Nervous System Diseases | 1 | 1997 | 286 | 0.100 |
Why?
| | Craniotomy | 1 | 2014 | 84 | 0.100 |
Why?
| | Macrophages, Peritoneal | 2 | 2004 | 89 | 0.100 |
Why?
| | Critical Care | 3 | 2013 | 702 | 0.100 |
Why?
| | Radiography, Thoracic | 2 | 2013 | 172 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 403 | 0.100 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 327 | 0.100 |
Why?
| | Motor Skills | 1 | 2014 | 104 | 0.100 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 130 | 0.100 |
Why?
| | Hemorrhage | 2 | 2016 | 822 | 0.100 |
Why?
| | Fluid Therapy | 1 | 2014 | 155 | 0.100 |
Why?
| | Predictive Value of Tests | 4 | 2013 | 2123 | 0.100 |
Why?
| | Tracheotomy | 1 | 2013 | 23 | 0.100 |
Why?
| | Contrast Media | 2 | 2015 | 497 | 0.100 |
Why?
| | Embolization, Therapeutic | 1 | 2015 | 243 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1711 | 0.090 |
Why?
| | Thrombophilia | 1 | 2013 | 89 | 0.090 |
Why?
| | Young Adult | 7 | 2025 | 14254 | 0.090 |
Why?
| | Urinalysis | 1 | 2013 | 83 | 0.090 |
Why?
| | Coronary Disease | 1 | 1995 | 382 | 0.090 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 54 | 0.090 |
Why?
| | Interleukin-10 | 3 | 2004 | 311 | 0.090 |
Why?
| | Vascular Surgical Procedures | 2 | 2012 | 343 | 0.090 |
Why?
| | Television | 1 | 1993 | 72 | 0.090 |
Why?
| | Forecasting | 1 | 2014 | 390 | 0.090 |
Why?
| | Blood Group Incompatibility | 1 | 2012 | 21 | 0.090 |
Why?
| | Phenytoin | 1 | 2012 | 21 | 0.090 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 96 | 0.090 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2012 | 8 | 0.090 |
Why?
| | Piracetam | 1 | 2012 | 14 | 0.090 |
Why?
| | Angiography, Digital Subtraction | 1 | 2012 | 48 | 0.090 |
Why?
| | Postoperative Complications | 6 | 2022 | 2977 | 0.090 |
Why?
| | Orthopedic Procedures | 1 | 2014 | 244 | 0.090 |
Why?
| | Electroencephalography | 1 | 2015 | 563 | 0.090 |
Why?
| | Vasodilation | 4 | 1999 | 521 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2016 | 777 | 0.090 |
Why?
| | Chemokines, CXC | 2 | 2002 | 68 | 0.090 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 271 | 0.080 |
Why?
| | Aged | 8 | 2025 | 26217 | 0.080 |
Why?
| | Neutrophil Infiltration | 2 | 2002 | 107 | 0.080 |
Why?
| | Thyroidectomy | 1 | 2011 | 94 | 0.080 |
Why?
| | Urinary Tract Infections | 1 | 2013 | 210 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 10 | 2002 | 2525 | 0.080 |
Why?
| | Acute Disease | 6 | 2021 | 1036 | 0.080 |
Why?
| | Fat Necrosis | 1 | 1990 | 12 | 0.080 |
Why?
| | Myocardium | 4 | 1993 | 935 | 0.080 |
Why?
| | Cardiovascular Agents | 1 | 2011 | 166 | 0.080 |
Why?
| | Specialties, Surgical | 1 | 2011 | 82 | 0.080 |
Why?
| | Endocrinology | 1 | 2011 | 77 | 0.080 |
Why?
| | Triamcinolone | 1 | 1989 | 12 | 0.080 |
Why?
| | Pericardium | 1 | 1990 | 59 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1547 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1582 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2002 | 376 | 0.080 |
Why?
| | Diaphragm | 2 | 2004 | 48 | 0.080 |
Why?
| | Chest Pain | 1 | 1990 | 99 | 0.080 |
Why?
| | Suppuration | 1 | 2009 | 9 | 0.070 |
Why?
| | Biopsy | 1 | 1993 | 1082 | 0.070 |
Why?
| | Anticonvulsants | 1 | 2012 | 246 | 0.070 |
Why?
| | Oxygen | 2 | 1994 | 981 | 0.070 |
Why?
| | Necrosis | 1 | 1990 | 244 | 0.070 |
Why?
| | Esophageal Stenosis | 1 | 1989 | 60 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2004 | 1217 | 0.070 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 290 | 0.070 |
Why?
| | Pulmonary Fibrosis | 1 | 1993 | 395 | 0.070 |
Why?
| | Perioperative Care | 1 | 2011 | 231 | 0.070 |
Why?
| | Middle Aged | 10 | 2025 | 36309 | 0.070 |
Why?
| | Pediatrics | 2 | 2011 | 1125 | 0.070 |
Why?
| | General Surgery | 1 | 2011 | 206 | 0.070 |
Why?
| | Asparaginase | 2 | 1998 | 32 | 0.070 |
Why?
| | Accidents, Traffic | 4 | 2011 | 193 | 0.070 |
Why?
| | Pulmonary Artery | 3 | 2000 | 1129 | 0.070 |
Why?
| | Aorta, Thoracic | 2 | 2021 | 287 | 0.060 |
Why?
| | Seizures | 1 | 2012 | 485 | 0.060 |
Why?
| | Cyclic AMP | 2 | 2001 | 208 | 0.060 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2005 | 189 | 0.060 |
Why?
| | Hernia, Inguinal | 2 | 1998 | 43 | 0.060 |
Why?
| | Patient Discharge | 2 | 2016 | 995 | 0.060 |
Why?
| | Pancreatitis | 2 | 1998 | 146 | 0.060 |
Why?
| | Biliary Atresia | 2 | 2000 | 158 | 0.060 |
Why?
| | Pilot Projects | 1 | 2012 | 1898 | 0.060 |
Why?
| | Endotoxemia | 3 | 2002 | 86 | 0.060 |
Why?
| | Mediastinal Neoplasms | 1 | 2006 | 53 | 0.060 |
Why?
| | Hepatic Artery | 1 | 2006 | 53 | 0.060 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2006 | 44 | 0.060 |
Why?
| | Mediastinum | 1 | 2005 | 23 | 0.060 |
Why?
| | Brachial Plexus | 1 | 2005 | 34 | 0.060 |
Why?
| | Rats, Inbred Strains | 8 | 1992 | 321 | 0.060 |
Why?
| | Signal Transduction | 2 | 2002 | 5224 | 0.060 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2005 | 14 | 0.060 |
Why?
| | Patient Care Team | 1 | 2011 | 697 | 0.060 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 121 | 0.060 |
Why?
| | Chemotactic Factors | 2 | 2002 | 43 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 740 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1925 | 0.050 |
Why?
| | Kidney | 3 | 2004 | 1497 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2006 | 174 | 0.050 |
Why?
| | Growth Substances | 2 | 2002 | 138 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2025 | 1475 | 0.050 |
Why?
| | Pulmonary Edema | 2 | 2002 | 105 | 0.050 |
Why?
| | Heparin | 2 | 2019 | 247 | 0.050 |
Why?
| | Cohort Studies | 1 | 2015 | 6033 | 0.050 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2005 | 117 | 0.050 |
Why?
| | Renal Veins | 1 | 2004 | 18 | 0.050 |
Why?
| | Leisure Activities | 1 | 2004 | 31 | 0.050 |
Why?
| | Renal Artery | 1 | 2004 | 43 | 0.050 |
Why?
| | Physical Examination | 2 | 2014 | 244 | 0.050 |
Why?
| | Thoracic Surgical Procedures | 1 | 2005 | 94 | 0.050 |
Why?
| | Intestinal Perforation | 1 | 2004 | 46 | 0.050 |
Why?
| | Peroxidase | 7 | 2002 | 168 | 0.050 |
Why?
| | Granuloma, Plasma Cell | 1 | 2003 | 12 | 0.050 |
Why?
| | Comorbidity | 3 | 2023 | 1662 | 0.050 |
Why?
| | Hernia, Diaphragmatic | 1 | 2003 | 67 | 0.050 |
Why?
| | Age Distribution | 5 | 2003 | 404 | 0.050 |
Why?
| | Animals | 24 | 2002 | 38102 | 0.050 |
Why?
| | Twins, Conjoined | 1 | 2003 | 6 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 163 | 0.050 |
Why?
| | Pleural Effusion | 1 | 2003 | 59 | 0.050 |
Why?
| | Rib Fractures | 1 | 2003 | 33 | 0.050 |
Why?
| | Vital Signs | 1 | 2023 | 46 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2003 | 180 | 0.050 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2022 | 37 | 0.050 |
Why?
| | Pancreatectomy | 1 | 2025 | 289 | 0.050 |
Why?
| | Anal Canal | 1 | 2003 | 102 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2003 | 116 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 136 | 0.050 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2002 | 25 | 0.050 |
Why?
| | Chemokine CXCL2 | 4 | 2002 | 41 | 0.040 |
Why?
| | Peritonitis | 1 | 2002 | 83 | 0.040 |
Why?
| | Rectum | 1 | 2003 | 182 | 0.040 |
Why?
| | Receptors, Cell Surface | 2 | 2002 | 372 | 0.040 |
Why?
| | Bites and Stings | 1 | 2001 | 30 | 0.040 |
Why?
| | Abnormalities, Multiple | 1 | 2003 | 199 | 0.040 |
Why?
| | Patients | 1 | 2023 | 183 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2001 | 162 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2004 | 507 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 479 | 0.040 |
Why?
| | Receptors, Interleukin-1 | 1 | 2002 | 211 | 0.040 |
Why?
| | Pulmonary Circulation | 2 | 1999 | 430 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 48 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 961 | 0.040 |
Why?
| | Joint Dislocations | 1 | 2000 | 60 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 214 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 28 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2019 | 28 | 0.040 |
Why?
| | Sex Distribution | 4 | 2002 | 388 | 0.040 |
Why?
| | Hydrogen Peroxide | 2 | 1992 | 335 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 264 | 0.040 |
Why?
| | Surgical Wound Infection | 1 | 2023 | 329 | 0.040 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 234 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2002 | 499 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 118 | 0.040 |
Why?
| | Morbidity | 2 | 2014 | 322 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1083 | 0.040 |
Why?
| | Salmonella typhi | 1 | 1998 | 12 | 0.040 |
Why?
| | Cervical Vertebrae | 1 | 2000 | 169 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2023 | 8347 | 0.040 |
Why?
| | Receptors, Adrenergic, alpha | 2 | 2000 | 19 | 0.030 |
Why?
| | Hernia, Femoral | 1 | 1998 | 4 | 0.030 |
Why?
| | Edema | 1 | 1999 | 125 | 0.030 |
Why?
| | Monocytes | 1 | 2001 | 539 | 0.030 |
Why?
| | Melanoma | 1 | 2005 | 762 | 0.030 |
Why?
| | Antigens, CD | 1 | 2001 | 558 | 0.030 |
Why?
| | Monokines | 3 | 2002 | 21 | 0.030 |
Why?
| | Octreotide | 1 | 1998 | 23 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2005 | 853 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 1999 | 134 | 0.030 |
Why?
| | Pneumonia | 1 | 2003 | 636 | 0.030 |
Why?
| | Analysis of Variance | 4 | 2004 | 1300 | 0.030 |
Why?
| | Cecal Diseases | 1 | 1997 | 3 | 0.030 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2011 | 499 | 0.030 |
Why?
| | Aorta | 1 | 2000 | 441 | 0.030 |
Why?
| | Survivors | 1 | 2020 | 523 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 733 | 0.030 |
Why?
| | Leukocyte Count | 2 | 2002 | 318 | 0.030 |
Why?
| | Perfusion | 3 | 1992 | 251 | 0.030 |
Why?
| | In Vitro Techniques | 3 | 1992 | 1049 | 0.030 |
Why?
| | Abdominal Pain | 1 | 1997 | 149 | 0.030 |
Why?
| | Portoenterostomy, Hepatic | 1 | 1996 | 43 | 0.030 |
Why?
| | Aspirin | 1 | 2019 | 406 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 4 | 0.030 |
Why?
| | Hepatic Duct, Common | 1 | 1996 | 5 | 0.030 |
Why?
| | Reoperation | 2 | 2012 | 637 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2016 | 197 | 0.030 |
Why?
| | Sepsis | 1 | 2002 | 664 | 0.030 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 1996 | 55 | 0.030 |
Why?
| | Ketone Bodies | 2 | 1992 | 16 | 0.030 |
Why?
| | Recovery of Function | 2 | 2015 | 716 | 0.030 |
Why?
| | Receptors, Purinergic P1 | 1 | 1994 | 30 | 0.030 |
Why?
| | Stomach Volvulus | 1 | 1994 | 2 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 853 | 0.030 |
Why?
| | Pneumothorax | 2 | 2005 | 52 | 0.030 |
Why?
| | Ventricular Pressure | 1 | 1994 | 52 | 0.030 |
Why?
| | Disease-Free Survival | 2 | 2006 | 770 | 0.030 |
Why?
| | Tetralones | 1 | 1993 | 1 | 0.030 |
Why?
| | Adenylyl Cyclases | 1 | 1994 | 60 | 0.030 |
Why?
| | Myocardial Reperfusion | 1 | 1993 | 56 | 0.020 |
Why?
| | Cardiac Output | 1 | 1994 | 179 | 0.020 |
Why?
| | Thoracoscopes | 1 | 1993 | 2 | 0.020 |
Why?
| | Administration, Oral | 1 | 2016 | 867 | 0.020 |
Why?
| | Conversion to Open Surgery | 1 | 2013 | 22 | 0.020 |
Why?
| | NF-kappa B | 3 | 2001 | 667 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 164 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1271 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1998 | 2028 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 1994 | 293 | 0.020 |
Why?
| | Oligopeptides | 2 | 1991 | 267 | 0.020 |
Why?
| | Acetoacetates | 1 | 1992 | 1 | 0.020 |
Why?
| | Surgical Sponges | 1 | 2012 | 5 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1992 | 15 | 0.020 |
Why?
| | Cost Control | 1 | 2012 | 38 | 0.020 |
Why?
| | Vertebral Artery | 1 | 2011 | 26 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 78 | 0.020 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2012 | 29 | 0.020 |
Why?
| | Carotid Artery Injuries | 1 | 2011 | 39 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 1993 | 285 | 0.020 |
Why?
| | Blood Coagulation | 1 | 2013 | 274 | 0.020 |
Why?
| | Chemokine CXCL1 | 2 | 2002 | 76 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 148 | 0.020 |
Why?
| | Fever | 1 | 2013 | 320 | 0.020 |
Why?
| | Lipid A | 1 | 1991 | 27 | 0.020 |
Why?
| | Pelvic Bones | 1 | 1993 | 134 | 0.020 |
Why?
| | Cytokines | 1 | 1999 | 2069 | 0.020 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 1991 | 31 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2016 | 390 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 208 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 44 | 0.020 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2011 | 47 | 0.020 |
Why?
| | Hospitals, University | 1 | 2011 | 176 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 1990 | 53 | 0.020 |
Why?
| | Enzyme Induction | 1 | 1990 | 88 | 0.020 |
Why?
| | Drug Costs | 1 | 2012 | 117 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2011 | 62 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 280 | 0.020 |
Why?
| | Antioxidants | 2 | 1991 | 550 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 201 | 0.020 |
Why?
| | Survival Analysis | 2 | 2003 | 1378 | 0.020 |
Why?
| | Cyclic GMP | 2 | 1999 | 90 | 0.020 |
Why?
| | Growth Disorders | 1 | 1989 | 89 | 0.020 |
Why?
| | RNA, Messenger | 3 | 2002 | 2805 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 1992 | 292 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1991 | 231 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2011 | 297 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2668 | 0.020 |
Why?
| | Shock, Septic | 1 | 1991 | 227 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 644 | 0.020 |
Why?
| | Liver Diseases | 1 | 1992 | 305 | 0.020 |
Why?
| | Radiology | 1 | 2011 | 174 | 0.020 |
Why?
| | Glutathione | 1 | 1990 | 370 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2011 | 463 | 0.020 |
Why?
| | Medical Oncology | 1 | 2011 | 340 | 0.020 |
Why?
| | Fractures, Bone | 1 | 1993 | 428 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2219 | 0.020 |
Why?
| | Thyroid Neoplasms | 1 | 2011 | 370 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 1990 | 1069 | 0.020 |
Why?
| | Enzyme Inhibitors | 2 | 2000 | 821 | 0.010 |
Why?
| | Serum Albumin | 3 | 1992 | 147 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 1992 | 675 | 0.010 |
Why?
| | Tissue Adhesions | 1 | 2006 | 34 | 0.010 |
Why?
| | Equipment Failure | 1 | 2006 | 115 | 0.010 |
Why?
| | Arm | 1 | 2005 | 110 | 0.010 |
Why?
| | Hydrocephalus | 1 | 2006 | 111 | 0.010 |
Why?
| | Hypertension, Renovascular | 1 | 2004 | 15 | 0.010 |
Why?
| | Posture | 1 | 2005 | 197 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 336 | 0.010 |
Why?
| | Rupture | 1 | 2004 | 91 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2003 | 15 | 0.010 |
Why?
| | Abdominal Abscess | 1 | 2003 | 26 | 0.010 |
Why?
| | Hemothorax | 1 | 2003 | 19 | 0.010 |
Why?
| | Jugular Veins | 1 | 2003 | 42 | 0.010 |
Why?
| | Rectovaginal Fistula | 1 | 2003 | 11 | 0.010 |
Why?
| | Gene Expression Regulation | 2 | 2004 | 2601 | 0.010 |
Why?
| | Appendix | 1 | 2003 | 31 | 0.010 |
Why?
| | Fetal Death | 1 | 2003 | 58 | 0.010 |
Why?
| | Zymosan | 1 | 2002 | 39 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 515 | 0.010 |
Why?
| | Safety | 1 | 2004 | 358 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2004 | 172 | 0.010 |
Why?
| | Medical Errors | 1 | 2003 | 119 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2002 | 254 | 0.010 |
Why?
| | Probability | 1 | 2002 | 308 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2001 | 41 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 185 | 0.010 |
Why?
| | Bucladesine | 1 | 2001 | 19 | 0.010 |
Why?
| | Diagnostic Errors | 1 | 2003 | 178 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 80 | 0.010 |
Why?
| | Catalase | 2 | 1992 | 134 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 157 | 0.010 |
Why?
| | Vinblastine | 2 | 1992 | 75 | 0.010 |
Why?
| | Toll-Like Receptor 2 | 1 | 2002 | 125 | 0.010 |
Why?
| | Spine | 1 | 2003 | 182 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2002 | 193 | 0.010 |
Why?
| | Nitrites | 1 | 2001 | 88 | 0.010 |
Why?
| | I-kappa B Proteins | 1 | 2001 | 75 | 0.010 |
Why?
| | Vagina | 1 | 2003 | 203 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 253 | 0.010 |
Why?
| | omega-N-Methylarginine | 1 | 2000 | 29 | 0.010 |
Why?
| | Nitrates | 1 | 2001 | 96 | 0.010 |
Why?
| | Guanidines | 1 | 2000 | 39 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 83 | 0.010 |
Why?
| | I-kappa B Kinase | 1 | 2000 | 51 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2001 | 123 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2004 | 466 | 0.010 |
Why?
| | Trachea | 1 | 2002 | 258 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1139 | 0.010 |
Why?
| | Toll-Like Receptor 4 | 1 | 2002 | 276 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 849 | 0.010 |
Why?
| | Dogs | 1 | 2001 | 478 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 162 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2004 | 780 | 0.010 |
Why?
| | Immunoblotting | 1 | 2000 | 295 | 0.010 |
Why?
| | Mice | 3 | 2002 | 18356 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2002 | 896 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 335 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2002 | 638 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2002 | 387 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 2000 | 365 | 0.010 |
Why?
| | Antibodies | 1 | 2001 | 397 | 0.010 |
Why?
| | Histamine Agonists | 1 | 1998 | 1 | 0.010 |
Why?
| | Dimaprit | 1 | 1998 | 3 | 0.010 |
Why?
| | Blood Circulation | 1 | 1998 | 44 | 0.010 |
Why?
| | Niacinamide | 1 | 1999 | 104 | 0.010 |
Why?
| | Vas Deferens | 1 | 1998 | 11 | 0.010 |
Why?
| | Benzamides | 1 | 1999 | 226 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2875 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1368 | 0.010 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 92 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 835 | 0.010 |
Why?
| | Placebo Effect | 1 | 1997 | 24 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1998 | 370 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2000 | 429 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 963 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 2110 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1999 | 500 | 0.010 |
Why?
| | Intraoperative Period | 1 | 1996 | 69 | 0.010 |
Why?
| | Hospital Costs | 1 | 1997 | 125 | 0.010 |
Why?
| | Graft Rejection | 1 | 2000 | 521 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4151 | 0.010 |
Why?
| | Energy Metabolism | 2 | 1993 | 935 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1478 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1996 | 2 | 0.010 |
Why?
| | Cholangiography | 1 | 1996 | 10 | 0.010 |
Why?
| | Traction | 1 | 1996 | 19 | 0.010 |
Why?
| | Gallbladder | 1 | 1996 | 15 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2000 | 364 | 0.010 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 1996 | 63 | 0.010 |
Why?
| | Dissection | 1 | 1996 | 57 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2000 | 1062 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 318 | 0.010 |
Why?
| | DNA | 1 | 2001 | 1437 | 0.010 |
Why?
| | Phenethylamines | 1 | 1993 | 16 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2000 | 3130 | 0.010 |
Why?
| | Adenosine | 1 | 1994 | 255 | 0.010 |
Why?
| | Norepinephrine | 1 | 1993 | 201 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 87 | 0.010 |
Why?
| | Nitroblue Tetrazolium | 1 | 1991 | 12 | 0.010 |
Why?
| | Ventricular Function | 1 | 1991 | 53 | 0.010 |
Why?
| | Tungsten | 1 | 1991 | 30 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4568 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1991 | 115 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1993 | 356 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 153 | 0.010 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 38 | 0.010 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1990 | 24 | 0.010 |
Why?
| | Azepines | 1 | 1991 | 105 | 0.010 |
Why?
| | Permeability | 1 | 1991 | 169 | 0.000 |
Why?
| | Endothelium | 1 | 1991 | 119 | 0.000 |
Why?
| | Triazoles | 1 | 1991 | 191 | 0.000 |
Why?
| | Cell Adhesion | 1 | 1991 | 451 | 0.000 |
Why?
| | Liver Transplantation | 1 | 1996 | 827 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1568 | 0.000 |
Why?
| | Biomechanical Phenomena | 1 | 1990 | 860 | 0.000 |
Why?
| | Proteins | 1 | 1991 | 1023 | 0.000 |
Why?
| | Diet | 1 | 1991 | 1278 | 0.000 |
Why?
|
|
Bensard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|